Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single Patient Investigational Treatment for Cree Leukoencephalopathy (Vanishing White Matter Disease)

NCT07300397 is registered in ClinicalTrials.gov with McGill University Health Centre/Research Institute of the McGill University Health Centre as lead sponsor.

NCT NCT07300397
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07300397 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single Patient Investigational Treatment for Cree Leukoencephalopathy (Vanishing White Matter Disease)
Lead sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
Phase
Not applicable
Overall status
Active, not recruiting
Start date
December 3, 2025
Completion date
January 3, 2029
Enrollment
1 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cree leukoencephalopathy